Hometown International (HWIN) 10-Q 12 Aug 22 2022 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2022	Aug. 12, 2022
Document Information Line Items
Entity Registrant Name	MAKAMER HOLDINGS, INC.
Trading Symbol	N/A
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		36,347,004
Amendment Flag	false
Entity Central Index Key	0001632081
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-207488
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	46-5705488
Entity Address, Address Line One	2934 N. Beverly Glen Circle
Entity Address, Address Line Two	Suite #338
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90077
City Area Code	(310)
Local Phone Number	692-4121
Title of 12(b) Security	None
Security Exchange Name	NONE
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets
Cash	$ 913,509	$ 72,288
Security deposit	20,487
Prepaid expenses	414,597
Assets from discontinued operations	8,505
Total Current Assets	1,357,098	72,288
Intangible assets	14,650	11,650
Operating lease asset	106,866
Total Assets	1,478,614	83,938
Current Liabilities
Accounts payable and accrued expenses	271,034	48,782
Notes payable - related party		184,990
Operating lease liability, current	74,562
Liabilities from discontinued operations	68,245
Total Current Liabilities	413,841	233,772
Long Term Liabilities
Operating lease liability, net of current	33,473
Total Liabilities	447,314	233,772
Commitments and Contingencies (See Note 5)
Stockholders’ Equity
Common stock, $0.0001 par value; 250,000,000 shares authorized, 36,347,004 and 26,132,421 issued and outstanding, respectively	3,635	2,613
Additional paid-in capital	10,592,569	179,087
Accumulated deficit	(9,564,904)	(331,534)
Total Stockholders’ Equity (Deficit)	1,031,300	(149,834)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 1,478,614	$ 83,938

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	36,347,004	26,132,421
Common stock, shares outstanding	36,347,004	26,132,421

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Income Statement [Abstract]
Sales
Costs and Expenses
Consulting	2,799,523	3,039,523
Research and Development	77,990	82,024
Professional fees	109,112	121,192
General and administrative	572,388	584,135
Total cost and expenses	3,559,013	3,826,874
Loss from Operations	(3,559,013)	(3,826,874)
Other Income
Interest Income	1	1
Total Other Income	1	1
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(3,559,012)	(3,826,873)
Provision for Income Taxes
Discontinued operations
Loss from discontinued operations	(5,406,497)	(5,406,497)
NET LOSS	$ (8,965,509)	$ (9,233,370)
Net income/(loss) per share - basic and diluted
Loss from continuing operations basic (in Dollars per share)	$ (0.1)	$ (0.12)
Loss from discontinuing operations basic (in Dollars per share)	(0.15)	(0.17)
Net loss per common share - basic (in Dollars per share)	$ (0.25)	$ (0.29)
Weighted average number of shares outstanding during the period - Basic (in Shares)	36,248,391	31,391,491

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Income Statement [Abstract]
Loss from continuing operations diluted	$ (0.10)	$ (0.12)
Loss from discontinuing operations diluted	(0.15)	(0.17)
Net loss per common share - diluted	$ (0.25)	$ (0.29)
Weighted average number of shares outstanding during the period - Diluted (in Shares)	36,248,391	31,391,491

Condensed Consolidated Statem_3

Condensed Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common stock	Additional paid-in capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 2,613	$ 179,087	$ (331,534)	$ (149,834)
Balance (in Shares) at Dec. 31, 2021	26,132,421
Shares issued for cash	$ 106	794,894		795,000
Shares issued for cash (in Shares)	1,060,708
Shares issuance in connection with the merger	$ 780	6,346,224		6,347,004
Shares issuance in connection with the merger (in Shares)	7,797,004
Share cancellation in connection with the merger	$ (145)	145
Share cancellation in connection with the merger (in Shares)	(1,450,000)
Shares issued for services	$ 281	3,272,219		3,272,500
Shares issued for services (in Shares)	2,806,871
Net loss			(9,233,370)	(9,233,370)
Balance at Jun. 30, 2022	$ 3,635	10,592,569	(9,564,904)	1,031,300
Balance (in Shares) at Jun. 30, 2022	36,347,004
Balance at Mar. 31, 2022	$ 2,737	1,183,963	(599,395)	587,305
Balance (in Shares) at Mar. 31, 2022	27,373,249
Shares issuance in connection with the merger	$ 780	6,346,224		6,347,004
Shares issuance in connection with the merger (in Shares)	7,797,004
Share cancellation in connection with the merger	$ (145)	145
Share cancellation in connection with the merger (in Shares)	(1,450,000)
Shares issued for services	$ 263	3,062,237		3,062,500
Shares issued for services (in Shares)	2,626,751
Net loss			(8,965,509)	(8,965,509)
Balance at Jun. 30, 2022	$ 3,635	$ 10,592,569	$ (9,564,904)	$ 1,031,300
Balance (in Shares) at Jun. 30, 2022	36,347,004

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited)	6 Months Ended
	Jun. 30, 2022 USD ($)
Statement of Cash Flows [Abstract]
Net loss from continuing operations	$ (3,826,873)
Net loss from discontinuing operations	(5,406,497)
Net Loss	(9,233,370)
Adjustments to reconcile net loss to net cash used in operations
Stock issued for services	3,272,500
Amortization of operating lease assets	12,025
Changes in operating assets and liabilities:
Increase in security deposits	(20,487)
Increase in prepaid expenses	(414,597)
Assets from discontinued operations	5,329,425
Increase in accounts payable and accrued expenses	222,252
Decrease in operating lease liability	(10,856)
Liabilities from discontinued operations	68,245
Net Cash Used in Operating Activities	(774,863)
Net Cash Used in Operating Activities – discontinued operations	(8,827)
Net Cash Used in Operating activities – continued operations	(766,036)
Cash Flows From Investing Activities:
Cash paid for patent	(3,000)
Cash acquired in acquisition of Makamer, Inc.	1,009,074
Net Cash Provided by Investing Activities	1,006,074
Net Cash Provided by Investing Activities – discontinued operations
Net Cash Provided by Investing activities – continued operations	1,006,074
Cash Flows From Financing Activities:
Proceeds from common stock issuance for cash	795,000
Repayment of note payable to related party	(184,990)
Net Cash Provided by Financing Activities	610,010
Net Cash Provided by Financing Activities – discontinued operations
Net Cash Provided by Financing activities – continued operations	610,000
Net Increase in Cash	841,221
Cash at Beginning of Period	72,288
Cash at End of Period	913,509
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:
Operating lease asset obtained for operating lease liability upon remeasurement	118,891
Common stock issued in connection with acquisition of Makamer, Inc.	$ 6,347,004

Organization and Nature of Oper

Organization and Nature of Operations	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Organization and Nature of Operations	Note 1 - Organization and Nature of Operations Organization and Nature of Operations The accompanying unaudited condensed consolidated unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 18, 2022 and Form 8-K/A for the year ended December 31, 2021, filed with the SEC on June 16, 2022. It is management’s opinion that all material adjustments (consisting of normal recurring adjustments) have been made, which are necessary for a fair financial statement presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year. On March 29, 2022, the Company filed a certificate of amendment with the Secretary of State of the State of Nevada in order to effectuate a name change to Makamer Holdings, Inc.. The Certificate of Amendment became effective on March 29, 2022. Makamer Holdings, Inc. (f/k/a Hometown International, Inc.) (the “Company”) was incorporated under the laws of the State of Nevada on May 19, 2014. Through its wholly owned subsidiary, Your Hometown Deli, LLC (“Your Hometown Deli”), the Company is the originator of a new “Delicatessen” concept, featuring “home-style” sandwiches and other entrees in a casual friendly atmosphere, designed to be comfortable community gathering places for guests of all ages. Targeted towards smaller towns and communities, the Company’s first and only store is located in Paulsboro, New Jersey. On January 18, 2014, Your Hometown Deli was formed under the laws of the State of New Jersey. On May 29, 2014, Your Hometown Deli entered into a Membership Interest Purchase Agreement with the Company. For accounting purposes, this transaction was accounted for as a merger of entities under common control and has been treated as a recapitalization of the Company with Your Hometown Deli as the accounting acquirer. The historical financial statements of the accounting acquirer became the financial statements of the registrant. The Company did not recognize goodwill or any intangible assets in connection with the transaction. The 5,000,000 shares issued to the shareholder of Your Hometown Deli in conjunction with the share exchange transaction has been presented as outstanding for all periods. On July 1, 2022, the Company disposed of Your Hometown Deli, LLC remaining inventory for a sales price of $700 (See Notes 7 and 9). On August 9, 2022, the Company disposed of its subsidiary Your Hometown Deli, LLC. All Your Hometown Deli, LLC transactions have been recorded as discontinued operations as of June 30, 2022 (See Notes 7 and 9). On April 1, 2022 (“effective date”), the Company, completed its acquisition of Makamer, Inc., a Delaware corporation (“Makamer”), which was organized on September 3, 2021, to develop and market biodegradable resins with the goal of replacing traditional plastics with renewable and compostable materials to help reduce worldwide toxic plastic waste pollution. Pursuant to the terms of the Agreement and Plan of Merger and Reorganization, dated March 25, 2022 (the “Merger Agreement”), by and among the Company, Makamer Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company (the “Merger Sub”), and Makamer, at the effective time of the Merger (the “Effective Time”), Merger Sub merged with and into Makamer, with Makamer continuing as the surviving entity and a wholly-owned subsidiary of the Company (the “Merger”). The entry into the Merger Agreement by the parties was previously reported in a Current Report on Form 8-K the Company filed with the SEC on March 31, 2022. The Merger became effective upon the filing of a Certificate of Merger with the Secretary of State of the State of Delaware on April 1, 2022 (See Note 8). On the effective date, of the Merger the stockholders of Makamer exchanged a total of 19,986,667 shares of Makamer common stock (representing 100% of Makamer’s outstanding shares) for an aggregate of 30,000,000 shares of common stock of the Company (the “Merger Shares”), with each Makamer stockholder receiving a pro rata portion (1.5 shares for each share held) of the Merger Shares based upon the total number of shares of Makamer common stock held by such Makamer stockholder immediately prior to the effective date. The transaction resulted in a change in control and was treated as a reverse acquisition (See Notes 4 and 8). In connection with the Merger, Makamer assigned its U.S. Provisional Patent Application No. 63/271,978, filed October 26, 2021, having the title “Biodegradable Plastic Composite Containing Fibers,” to the Company (See Note 8). The Company agreed that $1,000,000 of the Company’s cash will be used to expand Makamer’s business, including for sales and marketing, research and development, evaluating other synergistic acquisitions, and working capital and general corporate purposes (See Note 8). In connection with the Merger, certain pre-Merger stockholders of the Company agreed to return 1,450,000 shares of the Company’s common stock to the Company for cancellation within 30 days of the closing (the “Share Cancellation”). Following the issuance of the Merger Shares and the Share Cancelation, the Company will have an aggregate of 36,347,004 shares of common stock issued and outstanding (See Notes 4 and 8). The Company is committed to revolutionize the plastics industry with the state of the art bio-optimized technologies to keep thermoplastic out of landfills and environment. Makamer was founded on the basis to solve the crisis of plastic pollution through sustainability engineering which will fundamentally change the way the world interacts with Makamer packaging products. Makamer is a business whose planned principal operations are the research and development, manufacture, sales and marketing of bioplastics technologies and biodegradable products. The Company is currently conducting research and development activities advancing the bioplastics technologies and to operationalize certain provisional patented technologies that the Company owns so it can manufacture range of biodegradable products such as biodegradable resins, grocery bags, trash bags, straws, and cutleries etc. In September 2021, the Company secured a research facility in McMaster University at the Department of Chemical Engineering, which houses its key research and development activities. In May 2022, the Company further secured additional laboratory facility in Inglewood, California, which houses its employees and research and development activities in California. The Company also is in the process of raising additional equity capital to support the on-going development activities and to begin the scale up manufacturing, sales and marketing of resins and products as soon as possible. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology before another company develops similar technology. The Company’s accounting year end is December 31, which coincides with the fiscal year ends of each of our wholly owned subsidiaries, Your Hometown Deli, LLC and Makamer, Inc. Impact of COVID-19 The ongoing COVID-19 global and national health emergency has caused significant disruption in the international and United States economies and financial markets. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. The spread of COVID-19 has caused illness, quarantines, cancellation of events and travel, business and school shutdowns, reduction in business activity and financial transactions, labor shortages, supply chain interruptions and overall economic and financial market instability. The COVID-19 pandemic has the potential to significantly impact the Company’s supply chain, distribution centers, or logistics and other service providers. In addition, a severe prolonged economic downturn could result in a variety of risks to the business, including weakened demand for products and services and a decreased ability to raise additional capital when needed on acceptable terms, if at all. As the situation continues to evolve, the Company will continue to closely monitor market conditions and respond accordingly. To date, we have maintained uninterrupted business operations with normal turnaround times for servicing our customers. We have implemented adjustments to our operations designed to keep employees safe and comply with federal, state, and local guidelines, including those regarding social distancing. The extent to which COVID19 may further impact the Company’s business, results of operations, financial condition and cash flows will depend on future developments, which are highly uncertain and cannot be predicted with confidence. In response to COVID-19, the United States government has passed legislation and taken other actions to provide financial relief to companies and other organizations affected by the pandemic. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition, and results of operations. Liquidity, Going Concern and Management’s Plans These condensed unaudited financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the six months ended June 30, 2022, the Company had: ● Net loss from continuing operations of $3,826,873; and ● Net cash used in operating activities - continued operations was $766,036 Additionally, for the six months ended June 30, 2022, the Company had: ● Accumulated deficit of $9,564,904 ● Stockholders’ equity of $1,031,300; and ● Working capital of $943,257 The Company has cash on hand of $913,509 at June 30, 2022. Although the Company intends to raise additional debt (third party and related party lenders) or equity capital (historically shareholder capital contributions and third-party debt), the Company expects to incur losses from operations and have negative cash flows from operating activities for the near-term. These losses could be significant as the Company executes its business plan. These factors create substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period subsequent to the date that these financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business. Management’s strategic plans include the following: ● Pursuing additional capital raising opportunities, ● Continuing research and development on advancing bioplastics technologies, executing and commercializing its business operations, ● Continuing to secure supply chain and execute strategic partnering or distribution opportunities; and ● Identifying unique market opportunities that represent potential positive short-term cash flow.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Business Segments The Company uses the “management approach” to identify its reportable segments. The management approach requires companies to report segment financial information consistent with information used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. The Company has identified one single reportable operating segment. The Company manages its business on the basis of one operating and reportable segment. Use of Estimates Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material. Significant estimates during the six months ended June 30, 2022 and the year ended December 31, 2021, respectively, include valuation of intangible assets, valuation of stock-based compensation, estimated useful lives related to intangible assets, uncertain tax positions, and the valuation allowance on deferred tax assets. Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2 — Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and ● Level 3 — Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist us in determining fair value, as appropriate. Although the Company believes that the recorded fair value of our financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values. The Company’s financial instruments, including cash, is carried at historical cost. At June 30, 2022, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. ASC 825-10 “Financial Instruments” Cash and Cash Equivalents For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. At June 30, 2022 and December 31, 2021, respectively, the Company did not have any cash equivalents. Concentrations The Company maintains a bank account at one bank, which, at times, may have balance that exceeds the federally insured limit. The Company believes it is not exposed to any significant credit risk on its cash balance and has not experienced any losses in such account. At June 30, 2022 and December 31, 2021, the Company had a cash balance in excess of FDIC limits of $663,405 and $0, respectively. Goodwill and Intangible Assets We account for domain names and patents in accordance with ASC 350-30, General Intangibles Other than Goodwill. We capitalize patent costs representing legal fees associated with filing patent applications and amortize them on a straight-line basis. We are in the process of evaluating our patents’ estimated useful life and will begin amortizing the patents when they are brought to the market or otherwise commercialized. The Company initially records intangible assets at their estimated fair values and reviews these assets periodically for impairment. Goodwill represents the excess of the purchase price over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination and is tested at least annually for impairment. We completed our most recent goodwill impairment assessment during the second quarter of 2022, and determined that recorded $5,396,944 of impairment expense related to acquisition of Makamer, Inc. The impairment expense is included as part of discontinued operations (See Note 7). Impairment of Long-lived Assets Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15 “Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Income Taxes The Company accounts for income tax using the asset and liability method prescribed by ASC 740, “Income Taxes”. The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of June 30, 2022 and December 31, 2021, respectively, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. Management has evaluated and concluded that there are no material tax positions requiring recognition in the Company’s unaudited condensed financial statements as of June 30, 2022. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date. The Company’s 2019, 2020, and 2021 tax returns remain open for audit for Federal and State taxing authorities. Basic and Diluted Earnings (Loss) per Share Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. The computation of basic and diluted loss per share for June 30, 2022 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: June 30, Class A Warrants (Exercise price - $1.25/share) 38,985,020 Class B Warrants (Exercise price - $1.50/share) 38,985,020 Class C Warrants (Exercise price - $1.75/share) 38,985,020 Class D Warrants (Exercise price - $2.00/share) 38,985,020 Total 155,940,080 Related Parties Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. Recent Accounting Standards Changes to accounting principles are established by the FASB in the form of ASU’s to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our consolidated financial position, results of operations, stockholders’ deficit, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the FASB in the form of Accounting Standards Updates (“ASU”) through the date these financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective accounting pronouncements, when adopted, will have a material impact on the consolidated financial statements of the Company. In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. We adopted this pronouncement on January 1, 2022; however, the adoption of this standard did not have a material effect on the Company’s consolidated financial statements. In May 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company does not expect the adoption of this standard to have a material effect on the Company’s consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. While the Company is continuing to assess the timing of adoption and the potential impacts of ASU 2021-08, it does not expect ASU 2021-08 will have a material effect, if any, on its consolidated financial statements. Advertising Costs Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations. For the three and six months ended June 30, 2022, the Company recognized $2,303 and $3,458 in marketing and advertising costs. Stock-Based Compensation The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. When determining fair value, the Company considers the following assumptions in the Black-Scholes model: ● Exercise price, ● Expected dividends, ● Expected volatility, ● Risk-free interest rate; and ● Expected life of option Research and Development Research and development (“R&D”) costs are expensed as incurred. Major components of research and development costs include fees paid to consultants and other entities that conduct certain research and development activities on the Company’s behalf. Costs for research and development activities are recognized based on the terms of the individual arrangements, which may differ from the timing of receipt of invoices and payment of invoices and are reflected in the financial statements as an accrued expense. For the three and six months ended June 30, 2022, the Company expensed $82,024 and $77,990 in research and development costs. Operating Lease From time to time we may enter into operating lease or sub-lease agreements, including our corporate headquarters. We account for leases in accordance with ASC Topic 842: Leases, which requires a lessee to utilize the right-of-use model and to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either financing or operating, with classification affecting the pattern of expense recognition in the statement of operations. In addition, a lessor is required to classify leases as either sales-type, financing or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as financing. If the lessor does not convey risk and rewards or control, the lease is treated as operating. We determine if an arrangement is a lease, or contains a lease, at inception and record the lease in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term. Lease right-of-use assets and liabilities at commencement are initially measured at the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the information available at commencement to determine the present value of lease payments except when an implicit interest rate is readily determinable. We determine our incremental borrowing rate based on market sources including relevant industry data. We have lease agreements with lease and non-lease components and have elected to utilize the practical expedient to account for lease and non-lease components together as a single combined lease component, from both a lessee and lessor perspective with the exception of direct sales-type leases and production equipment classes embedded in supply agreements. From a lessor perspective, the timing and pattern of transfer are the same for the non-lease components and associated lease component and, the lease component, if accounted for separately, would be classified as an operating lease. We have elected not to present short-term leases on the balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that we are reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of our leases do not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments. Our leases, where we are the lessee, do not include an option to extend the lease term. Our lease also includes an option to terminate the lease prior to the end of the agreed upon lease term. For purposes of calculating lease liabilities, lease term would include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, included as a component of general and administrative expenses, in the accompanying statements of operations. Certain operating leases provide for annual increases to lease payments based on an index or rate, our lease has no stated increase, payments were fixed at lease inception. We calculate the present value of future lease payments based on the index or rate at the lease commencement date. Differences between the calculated lease payment and actual payment are expensed as incurred. See Note 5. Inventories Inventories consist of food and beverages and are stated at cost and are included in assets from discontinued operations.

Notes Payable- Related Party

Notes Payable- Related Party	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Notes Payable- Related Party	Note 3 – Notes Payable- Related Party On October 1, 2021, the Company issued a promissory note to the Company’s President for $24,990. The note was unsecured, non-interest bearing and due on demand. On March 15, 2022, the Company repaid $24,990. As of June 30, 2022, the balance was fully repaid (See Note 6). On October 2, 2021, the Company issued a promissory note to an entity controlled by the Company’s President for $350,000. The note was unsecured, non-interest bearing and due in three years. During the period ended December 31, 2021, the Company repaid $190,000. As of December 31, 2021, the balance was $160,000. During February and March 2022, the Company repaid $160,000. As of June 30, 2022, the balance was fully repaid (See Note 6).

Stockholders_ Deficit

Stockholders’ Deficit	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Stockholders’ Deficit	Note 4 – Stockholders’ Deficit Increase in Authorized Shares On March 23, 2020, the Company filed a Certificate of Amendment to the Company’s Articles of Incorporation with the Secretary of State of the State of Nevada, increasing the number of shares of common stock the Company is authorized to issue from 100,000,000 to 250,000,000, with a par value of $0.0001 per share. Warrant Issuance As of the date of this report, no warrants have been exercised. Number of Weighted Weighted Balance, December 31, 2021 155,940,080 $ 1.625 13.25 Granted - - - Exercised - - - Cancelled/Forfeited - - - Balance, June 30, 2022 (Unaudited) 155,940,080 $ 1.625 12.76 For the six months ended June 30, 2022, the intrinsic value for the warrants were $1,343,423,789. For the six months ended June 30, 2022, the following warrants were outstanding: Exercise Price Warrants Weighted Average Aggregate $ 1.25 38,985,020 12.76 $ 350,475,330 $ 1.50 38,985,020 12.76 $ 340,729,075 $ 1.75 38,985,020 12.76 $ 330,982,820 $ 2.00 38,985,020 12.76 $ 321,236,565 For the year ended December 31, 2021, the following warrants were outstanding: Exercise Price Warrants Weighted Average Aggregate $ 1.25 38,985,020 13.25 $ 436,632,224 $ 1.50 38,985,020 13.25 $ 426,885,969 $ 1.75 38,985,020 13.25 $ 417,139,714 $ 2.00 38,985,020 13.25 $ 407,393,459 Stock Issued for Services In March 2022, the Company issued 180,120 shares of common stock each to two consultants for aggregate consideration of $210,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 5). On April 1, 2022, the Company issued 2,626,751 shares of common stock each to various consultants for aggregate consideration of $3,062,500 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 5). Stock Issued for Cash From January to March 2022, the Company issued 1,060,708 shares of common stock for $795,000 ($1 - $2/share). Stock Issued in Connection with Merger and Share Cancellation In connection with the Merger, certain pre-Merger stockholders of the Makamer Holdings, Inc. agreed to return 1,450,000 shares of the Makamer Holdings, Inc. common stock to the Makamer Holdings, Inc. for cancellation within 30 days of the closing (the “Share Cancellation”). The Share Cancellation has not yet occurred (See Note 8). In connection with the Merger, the Company issued 7,797,004 shares of Company’s “Merger Shares”, with a fair value of $6,347,004.

Commitments

Commitments	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 5 – Commitments Employment Agreements – Related Parties On September 13, 2021, the Company entered into an employment agreement with its President, effective October 1, 2021. The initial term of the agreement is through October 1, 2024, at an annual salary of $120,000. An annual salary will increase to $350,000 upon Company’s common stock listed from OTC Markets-Pink Sheets to NASDAQ (the “Uplist”) or becoming a publicly traded Company. In addition, for each calendar year ending during the term of the agreement, the employee is eligible to receive an annual bonus with a target amount equal to 55% of the base salary earned by the employee. The employee is also entitled to a performance bonus of $100,000 if the Company merges with public Company or if the stock becomes public and trading on a public exchange or if the employee arranges for a documentary to be produced based on the Company, which is schedule to be released on television, streaming, or otherwise widely distributed. The employee was also granted 24,016,010 shares of the Company’s stock at the beginning of employment. The Company valued these shares at $0.0001/share with a fair value of $1,600. During the employment period, the employee is also entitled to a guaranteed annual bonus for $100,000 for the first year of employment and $350,000 for each of the second and third year of employment. The guaranteed bonus is to be paid on a semi-annual basis with the first payment due six months from the date of the agreement. Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. On June 21, 2022, the Company amended the agreement for the performance bonus. The employee is entitled a bonus of $100,000 if the Company merges with public Company and $100,000 if a documentary is produced on a television network. The company is also to reimburse the employee for any and all related federal, state and local taxes for the Company. For the six months ended June 30, 2022, the employee received a compensation of $308,076 and accrued compensation of $107,500 (See Note 6). On September 13, 2021, the Company entered into an employment agreement with its Chief Financial Officer, effective October 1, 2021. The initial term of the agreement is through October 1, 2024, at an annual salary of $120,000. An annual salary will increase to $220,000 upon Company’s common stock listed from OTC Markets-Pink Sheets to NASDAQ (the “Uplist”) or becoming a publicly traded Company. In addition, for each calendar year ending during the term of the agreement, the employee is eligible to receive an annual bonus with a target amount equal to 55% of the base salary earned by the employee. The employee was also granted 1,350,901 shares of the Company’s stock at the beginning of employment. The Company valued these shares at $0.0001/share with a fair value of $900. During the employment period, the employee is also entitled to a guaranteed annual bonus for $100,000 for the first year of employment and $350,000 for each of the second and third year of employment. The guaranteed bonus is to be paid on a semi-annual basis with the first payment due six months from the date of the agreement. Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. As of April 1, 2022, employee monthly salary is reduced to $5,000 per month. For the six months ended June 30, 2022, the employee received a compensation of $15,000 and accrued compensation of $50,000 (See Note 6). Employment Agreements On September 15 , 2021, the Company entered into an employment agreement with an employee at an annual salary of $120,000 effective October 1, 2021. Starting January 1, 2022 the annual salary became $60,000. In addition, for each calendar year ending during the term of the agreement, the employee is eligible upon the Company’s discretion an annual bonus equal to 5% of the base salary. Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. The employee will also be granted 375,000 shares of the Company’s stock upon Company up list or becoming a publicly traded Company. In April 2022, the Company issued 562,875 pro-rata shares of common stock for consideration of $656,250 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). For the six months ended June 30, 2022, the employee received a compensation of $15,000. Consulting Agreement – Related Party On October 1, 2021, the Company entered into a consulting agreement with its Chief Operating Officer to provide consulting services and operation duties. The agreement will continue, until either party terminates, at a monthly project fee of $5,000. The consultant will also receive 1.5% of the funding as compensation for his role in raising funds for company after Company receives $5,000,000 in funding that results from consultants efforts. The consultant is also eligible to receive 60,090 shares of Common stock in 180 days upon the execution of the agreement and an additional 40,000 shares of Common Stock one year after entering the consulting agreement. Effective November 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. In March 2022, the Company issued 90,000 shares of common stock for consideration of $105,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Notes 4 and 6). Consulting Agreements Effective as of April 26, 2021, the Company entered into a Consulting Agreement with Benchmark Capital, LLC, a limited liability company formed under the laws of New Jersey (“Benchmark”). Pursuant to this agreement, Benchmark was engaged as a consultant to the Company, to assist with all filing requirements with the SEC. The term of the agreement is month-to-month; provided, however On September 13, 2021, the Company entered into a consulting agreement to provide research and development services, effective October 1, 2021. The agreement will continue, until either party terminates, at a monthly project fee of $10,000. The consultant is also eligible to receive 375,000 shares of Common stock upon Company becoming public. In April 2022, the Company issued 562,875 pro-rata shares of common stock for consideration of $656,250 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). For the three and six months ended June 30, 2022, the Company expensed $30,000 as a component of general and administrative expenses in the statements of operations. On October 1, 2021, the Company entered into a consulting agreement with its Chief Investment Officer to raise capital and investor relations. The agreement will continue, until either party terminates, at a monthly project fee of $5,000. The consultant will also receive 1.5% of the funding as compensation for his role in raising funds for company after Company receives $5,000,000 or more in funds that results from consultants efforts. The consultant is also eligible to receive 60,000 shares of Common stock 180 days upon the execution of the agreement, and additional 40,000 shares of Common Stock upon 360 days. Effective November 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. In March 2022, the Company issued 90,000 shares of common stock for consideration of $105,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). On October 1, 2021, the Company entered into a consulting agreement to serve as a VP of Health and Education and to provide services in health and education awareness, sales and marking development. The agreement has a one-year term. The Consultant is to receive 20,000 shares of company stock upon Company merging or becoming public. In April 2022, the Company issued 30,020 pro-rata shares of common stock for consideration of $35,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). In Addition, on April 1, 2022, the Company entered into a service agreement, the agreement will continue, until either party terminates, at a monthly project fee of $5,000. On October 1, 2021, the Company entered into a consulting agreement to provide advisory services. The agreement has a term of eighteen months from the effective date. The agreement can be terminated at any time. The consultant is to receive 300,000 shares of company stock upon Company merging or becoming public. In April 2022, the Company issued 450,300 pro-rata shares of common stock for consideration of $525,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). On October 1, 2021, the Company entered into a consulting agreement to provide sales and advisory services. The agreement has a one-year term. The consultant is to receive 50,000 shares of company stock. In Addition, on April 1, 2022, the Company entered into a six-month service agreement at a monthly project fee of $5,000. In April 2022, the Company issued 75,050 pro-rata shares of common stock for consideration of $87,500 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). Pursuant to the consulting agreement, which includes a performance provision as well as a provision that the consultant must be employed as a condition of vesting the consideration, $52,500 was recorded as a prepaid expense. On October 1, 2021, the Company entered into a consulting agreement to provide public relations services on capital raising and investor relations. The agreement has an eighteen-month term. The consultant is to receive 400,000 shares of company stock upon Company merging or becoming public. In April 2022, the Company issued 600,400 pro-rata shares of common stock for consideration of $700,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). Pursuant to the consulting agreement, which includes a performance provision as well as a provision that the consultant must be employed as a condition of vesting the consideration, $350,000 was recorded as a prepaid expense. On October 1, 2021, the Company entered into a consulting agreement to provide advisory services and consulting services. The agreement has an eight-month term. The consultant is to receive 200,000 shares of company stock per share upon Company merging or becoming public In April 2022, the Company issued 300,200 pro-rata shares of common stock for consideration of $350,000 consisting of services rendered and recorded as prepaid compensation. The Company valued these shares at $1.75/share (See Note 4). On October 1, 2021, the Company entered into a consulting agreement to provide legal services. The consultant is to receive 10,000 shares of company stock per share upon Company merging or becoming public. In April 2022, the Company issued 15,010 pro-rata shares of common stock for consideration of $17,500 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 4). On October 1, 2021, the Company entered into a consulting agreement to provide marketing and advertising services. The agreement has a one-year term. The consultant is to receive 20,000 shares of company stock upon Company merging or becoming public. In addition, on April 1, 2022, the Company entered into a six-month service agreement at a monthly project fee of $5,000. In April 2022, the Company issued 30,020 pro-rata shares of common stock for consideration of $35,000 consisting of services rendered recorded as prepaid compensation. The Company valued these shares at $1.75/share (See Note 4). The agreement was terminated on July 31, 2022. Fee Sharing Agreement On May 3, 2022, the Company entered into a fee sharing agreement with a consultant. The Company will pay the consultant 6% of the price of the products sold originated by the consultant. Research and Development Agreement On September 27, 2021, the Company entered into research and development agreement to further advance, develop and commercialize certain technologies and treatments. The Company will pay developmental and regulatory milestone payments as incurred. Operating Lease Agreements The Company executed a sub-lease for the period from May 5, 2022, through November 30, 2023. Operating lease assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease right-of-use (ROU) asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any. In calculating the present value of the revised lease payments, the Company elected to utilize its incremental borrowing rate based on the lease terms as of the May 3, 2022. This rate was determined to be 10%, and the Company determined the initial present value, at inception, of $118,891. The Company is required to make payments of $6,479 per month for year one (May 2022 – October 2022) and $6,829 per month for year two (November 2022 – November 2023) as follows for the years ended December 31. For the three and six months ended June 30, 2022, the Company had a rent expense of $14,127 and $14,127, respectively. The Company also paid a security deposit of $20,487. The future minimum payments are as follows: 2022 $ 39,574 2023 75,119 Total $ 114,693 On July 1, 2014, the Company entered into a five-year non-cancelable operating lease with a related party for its store space in Paulsboro, NJ, at a monthly rate of $500. On September 21, 2015, the Company executed the lease and opened the delicatessen on October 14, 2015. On December 29, 2015, the Company signed an addendum to the lease, which provided that the lease agreement would commence 30 days after the opening of the delicatessen. The delicatessen opened on October 14, 2015, and the first payments would have been due on November 15, 2015, however, since the delicatessen was not fully functioning, the first monthly rent payment was not due until January 1, 2016. On August 12, 2019, the Company was granted a two-year extension of the lease. On March 22, 2021, the Company was granted an additional two-year extension of the lease (See Note 6). The Company accounts for the lease in accordance with ASC Topic 842, “Leases”. For the three and six months ended June 30, 2022, the Company had a rent expense of $1,500 and $1,500, respectively. The transactions have been recorded as discontinued operations as of June 30, 2022. Operating lease assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. The operating lease right-of-use (ROU) asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred, if any. In calculating the present value of the revised lease payments, the Company elected to utilize its incremental borrowing rate based on the revised lease terms as of the March 22, 2021, re-measurement date. This rate was determined to be 10%, and the Company determined the initial present value, at inception, of $10,569. The lease expense is recognized over the expected term on a straight-line basis. Operating leases are recognized on the balance sheet as operating lease assets, current operating lease liabilities and non-current operating lease liabilities. Supplemental consolidated balance sheet information related to leases was as follows: June 30, (Unaudited) Operating lease assets - right of use $ 106,866 Lease liability is summarized below: Lease Liability $ 108,035 Less: operating lease liability, current (74,562 ) Long term operating lease liability $ 33,473 Maturities of lease liabilities at June 30, 2022 are as follows: 2022 $ 39,574 2023 75,119 Total lease liability 114,693 Less: present value discount (6,658 ) Total lease liability $ 108,035 Supplemental disclosures of cash flow information related to leases were as follows: For the (Unaudited) Cash paid for operating lease liabilities $ 14,127 For the three and six months ended June 30, 2022, the total lease costs were $14,127 and $14,127, respectively. The Company did not incur any variable lease cost for both periods.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 – Related Party Transactions On September 13, 2021, the Company entered into an employment agreement with its President, effective October 1, 2021. The initial term of the agreement is through October 1, 2024, at an annual salary of $120,000. An annual salary will increase to $350,000 upon Company’s common stock listed from OTC Markets-Pink Sheets to NASDAQ (the “Uplist”) or becoming a publicly traded Company. In addition, for each calendar year ending during the term of the agreement, the employee is eligible to receive an annual bonus with a target amount equal to 55% of the base salary earned by the employee. The employee is also entitled to a performance bonus of $100,000 if the Company merges with public Company or if the stock becomes public and trading on a public exchange or if the employee arranges for a documentary to be produced based on the Company, which is schedule to be released on television, streaming, or otherwise widely distributed. The employee was also granted 24,016,010 shares of the Company’s stock at the beginning of employment. The Company valued these shares at $0.0001/share with a fair value of $1,600. During the employment period, the employee is also entitled to a guaranteed annual bonus for $100,000 for the first year of employment and $350,000 for each of the second and third year of employment. The guaranteed bonus is to be paid on a semi-annual basis with the first payment due six months from the date of the agreement. Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. On June 21, 2022, the Company amended the agreement for the performance bonus. The employee is entitled a bonus of $100,000 if the Company merges with public Company and $100,000 if a documentary is produced on a television network. The company is also to reimburse the employee for any and all related federal, state and local taxes for the Company. For the six months ended June 30, 2022, the employee received a compensation of $308,076 and accrued compensation of $107,500 (See Note 5). On September 13, 2021, the Company entered into an employment agreement with its Chief Financial Officer, effective October 1, 2021. The initial term of the agreement is through October 1, 2024, at an annual salary of $120,000. An annual salary will increase to $220,000 upon Company’s common stock listed from OTC Markets-Pink Sheets to NASDAQ (the “Uplist”) or becoming a publicly traded Company. In addition, for each calendar year ending during the term of the agreement, the employee is eligible to receive an annual bonus with a target amount equal to 55% of the base salary earned by the employee. The employee was also granted 1,350,901 shares of the Company’s stock at the beginning of employment. The Company valued these shares at $0.0001/share with a fair value of $900. During the employment period, the employee is also entitled to a guaranteed annual bonus for $100,000 for the first year of employment and $350,000 for each of the second and third year of employment. The guaranteed bonus is to be paid on a semi-annual basis with the first payment due six months from the date of the agreement. Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. As of April 1, 2022, employee monthly salary is reduced to $5,000 per month. For the six months ended June 30, 2022, the employee received a compensation of $15,000 and accrued compensation of $50,000 (See Note 5). On October 1, 2021, the Company entered into a consulting agreement with its Chief Operating Officer to provide consulting services and operation duties. The agreement will continue, until either party terminates, at a monthly project fee of $5,000. The consultant will also receive 1.5% of the funding as compensation for his role in raising funds for company after Company receives $5,000,000 in funding that results from consultants efforts. The consultant is also eligible to receive 60,090 shares of Common stock in 180 days upon the execution of the agreement and an additional 40,000 shares of Common Stock one year after entering the consulting agreement. Effective November 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. In March 2022, the Company issued 90,000 shares of common stock for consideration of $105,000 consisting of services rendered. The Company valued these shares at $1.75/share (See Note 5). On October 1, 2021, the Company issued a promissory note to the Company’s President for $24,990. The note was unsecured, non-interest bearing and due on demand. On March 15, 2022, the Company repaid $24,990. As of June 30, 2022, the balance was fully repaid (See Note 3). On October 2, 2021, the Company issued a promissory note to an entity controlled by the Company’s President for $350,000. The note was unsecured, non-interest bearing and due in three years. During the period ended December 31, 2021, the Company repaid $190,000. As of December 31, 2021, the balance was $160,000. During February and March 2022, the Company repaid $160,000. As of June 30, 2022, the balance was fully repaid (See Note 3). On July 1, 2014, the Company entered into a five-year non-cancelable operating lease with a related party for its store space in Paulsboro, NJ at a monthly rate of $500. On September 21, 2015, the Company executed the lease and opened the delicatessen on October 14, 2015. On December 29, 2015, the Company signed an addendum to the lease, which provided that the lease agreement would commence 30 days after the opening of the delicatessen. The delicatessen opened on October 14, 2015, and the first payment would have been due on November 15, 2015, however, since the delicatessen was not fully functioning, the first monthly rent payment was not due until January 1, 2016. On August 12, 2019, the Company was granted a two-year extension of the lease. On March 22, 2021, the Company was granted an additional two-year extension of the lease. For the three and six months ended June 30, 2022, the Company had a rent expense of $1,500 and $1,500, respectively, and included as discontinued operations (See Notes 5 and 7). During the year ended December 31, 2021, certain former officers paid a net aggregate $1,000 in expenses on Company’s behalf as an advance. Pursuant to the terms of the advance, the loan was non-interest bearing, unsecured and due on demand. As of June 30, 2022, the balance due to former officers was $62,297 and is included as discontinued operations (See Note 7 ).

Discontinued Operations

Discontinued Operations	6 Months Ended
	Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Note 7 – Discontinued Operations The Company is in the process of negotiating the sale of Your Hometown Deli, LLC. All Your Hometown Deli, LLC transactions have been recorded as discontinued operations as of June 30, 2022. The following table illustrates the reporting of the discontinued operations included in the Consolidated Balance Sheet as of June 30, 2022. June 30, (Unaudited) Current Assets Cash $ 1,598 Inventory 1,220 Operating lease asset 5,687 Total Assets from Discontinued Operations $ 8,505 Current Liabilities Accounts payable and accrued expenses $ 261 Due to former officers 62,297 Operating lease liability 5,687 Total Liabilities from Discontinued Operations $ 68,245 The following table illustrates the reporting of discontinued operations included in the Consolidated Statements of Operations for the period from January 1, 2022 to June 30, 2022. For the Six June 30, (Unaudited) Sales $ 3,349 Costs and Expenses Food, beverage and supplies 3,978 Labor 3,605 Direct operating and occupancy 1,632 Professional fees 567 General and administrative 3,120 Goodwill impairment expense 5,396,944 Total cost and expenses 5,409,846 LOSS FROM DISCONTINUED OPERATIONS BEFORE INCOME TAXES (5,406,497 ) Provision for Income Taxes - LOSS FROM DISCONTINUED OPERATIONS $ (5,406,497 )

Plan of Merger and Reorganizati

Plan of Merger and Reorganization and Reverse Acquisition	6 Months Ended
	Jun. 30, 2022
Plan of Merger and Reorganization and Reverse Acquisition [Abstract]
Plan of Merger and Reorganization and Reverse Acquisition	Note 8 – Plan of Merger and Reorganization and Reverse Acquisition On April 1, 2022, Makamer Holdings, Inc. (f/k/a Hometown International, Inc.), a Nevada corporation (the “Company”), completed its acquisition of Makamer, Inc., a Delaware corporation (“Makamer”), which was organized on September 3, 2021, to develop and market biodegradable resins with the goal of replacing traditional plastics with renewable and compostable materials to help reduce worldwide toxic plastic waste pollution. Pursuant to the terms of the Agreement and Plan of Merger and Reorganization, dated March 25, 2022 (the “Merger Agreement”), by and among the Company, Makamer Acquisition Corp., a Delaware corporation and wholly owned subsidiary of the Company (the “Merger Sub”), and Makamer, at the effective time of the Merger (the “Effective Time”), Merger Sub merged with and into Makamer, with Makamer continuing as the surviving entity and a wholly-owned subsidiary of the Company (the “Merger”). The entry into the Merger Agreement by the parties was previously reported in a Current Report on Form 8-K the Company filed with the SEC on March 31, 2022. The Merger became effective upon the filing of a Certificate of Merger with the Secretary of State of the State of Delaware on April 1, 2022. At the Effective Time of the Merger, the stockholders of Makamer exchanged a total of 19,986,667 shares of Makamer common stock (representing 100% of Makamer’s outstanding shares) for an aggregate of 30,000,000 shares of common stock of the Company (the “Merger Shares”), with each Makamer stockholder receiving a pro rata portion of the Merger Shares based upon the total number of shares of Makamer common stock held by such Makamer stockholder immediately prior to the Effective Time. In connection with the Merger, Makamer assigned its U.S. Provisional Patent Application No. 63/271,978, filed October 26, 2021, having the title “Biodegradable Plastic Composite Containing Fibers,” to the Company. The Company agreed that $1,000,000 of the Company’s cash will be used to expand Makamer’s business, including for sales and marketing, research and development, evaluating other synergistic acquisitions, and working capital and general corporate purposes. In connection with the Merger, certain pre-Merger stockholders of the Makamer Holdings, Inc. agreed to return 1,450,000 shares of the Makamer Holdings, Inc. common stock to the Makamer Holdings, Inc. for cancellation within 30 days of the closing (the “Share Cancellation”). The Share Cancellation has not yet occurred. Following the issuance of the Merger Shares and the Share Cancelation, Makamer Holdings, Inc. will have an aggregate of 36,347,004 shares of common stock issued and outstanding. As a result of the acquisition, the Company recognized Goodwill of $5,396,944. At June 30, 2022 it was determined by management to write off the value of the goodwill due to lack of business generated resulting in impairment of $5,396,944. The impairment expense is included as part of discontinued operations (See Note 7). This acquisition was treated as a business combination and the Company recorded the fair value of the net assets acquired. The table below summarizes preliminary estimated fair value of the assets acquired at the effective acquisition date. Consideration Common stock (6,347,004 shares of common stock ($1/share)) $ 6,347,004 Fair value of consideration transferred 6,347,004 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash 1,009,074 Inventory 3,691 Operating Lease Asset 7,023 Total assets acquired 1,019,788 Accounts payable and accrued expenses 408 Operating lease liability 7,023 Due to former officers 62,297 Total liabilities assumed 69,728 Total identifiable net assets 950,060 Goodwill $ 5,396,944

Subsequent Event - Deconsolidat

Subsequent Event - Deconsolidation of Subsidiary	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Event - Deconsolidation of Subsidiary	Note 9 – Subsequent Event - Deconsolidation of Subsidiary In accordance with ASC Topic 810-10-40, a parent company must deconsolidate a subsidiary as of the date the parent ceases to have a controlling interest in that subsidiary and recognize a gain or loss in net income at that time. On July 1, 2022, the Company disposed of Your Hometown Deli, LLC remaining inventory for a sales price of $700. On August 9, 2022, the Company disposed of its subsidiary Your Hometown Deli, LLC for a price of $15,000, consisting of $5,000 to be paid in cash and $10,000 note receivable. The note receivable for $10,000, bearing interest at 8%, and due ninety days from the issuance of the note.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Business Segments	Business Segments The Company uses the “management approach” to identify its reportable segments. The management approach requires companies to report segment financial information consistent with information used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. The Company has identified one single reportable operating segment. The Company manages its business on the basis of one operating and reportable segment.
Use of Estimates	Use of Estimates Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material. Significant estimates during the six months ended June 30, 2022 and the year ended December 31, 2021, respectively, include valuation of intangible assets, valuation of stock-based compensation, estimated useful lives related to intangible assets, uncertain tax positions, and the valuation allowance on deferred tax assets.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (“FASB”) ASC 820, Fair Value Measurements The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows: ● Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2 — Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and ● Level 3 — Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions. The determination of fair value and the assessment of a measurement’s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Level 3 valuations may require the use of various cost, market, or income valuation methodologies applied to unobservable management estimates and assumptions. Management’s assumptions could vary depending on the asset or liability valued and the valuation method used. Such assumptions could include estimates of prices, earnings, costs, actions of market participants, market factors, or the weighting of various valuation methods. The Company may also engage external advisors to assist us in determining fair value, as appropriate. Although the Company believes that the recorded fair value of our financial instruments is appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values. The Company’s financial instruments, including cash, is carried at historical cost. At June 30, 2022, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. ASC 825-10 “Financial Instruments”
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of the statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. At June 30, 2022 and December 31, 2021, respectively, the Company did not have any cash equivalents.
Concentrations	Concentrations The Company maintains a bank account at one bank, which, at times, may have balance that exceeds the federally insured limit. The Company believes it is not exposed to any significant credit risk on its cash balance and has not experienced any losses in such account. At June 30, 2022 and December 31, 2021, the Company had a cash balance in excess of FDIC limits of $663,405 and $0, respectively.
Goodwill and Intangible Assets	Goodwill and Intangible Assets We account for domain names and patents in accordance with ASC 350-30, General Intangibles Other than Goodwill. We capitalize patent costs representing legal fees associated with filing patent applications and amortize them on a straight-line basis. We are in the process of evaluating our patents’ estimated useful life and will begin amortizing the patents when they are brought to the market or otherwise commercialized. The Company initially records intangible assets at their estimated fair values and reviews these assets periodically for impairment. Goodwill represents the excess of the purchase price over the fair value of identifiable tangible and intangible assets acquired and liabilities assumed in a business combination and is tested at least annually for impairment. We completed our most recent goodwill impairment assessment during the second quarter of 2022, and determined that recorded $5,396,944 of impairment expense related to acquisition of Makamer, Inc. The impairment expense is included as part of discontinued operations (See Note 7).
Impairment of Long-lived Assets	Impairment of Long-lived Assets Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15 “Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.
Income Taxes	Income Taxes The Company accounts for income tax using the asset and liability method prescribed by ASC 740, “Income Taxes”. The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of June 30, 2022 and December 31, 2021, respectively, the Company had no uncertain tax positions that qualify for either recognition or disclosure in the financial statements. Management has evaluated and concluded that there are no material tax positions requiring recognition in the Company’s unaudited condensed financial statements as of June 30, 2022. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date. The Company’s 2019, 2020, and 2021 tax returns remain open for audit for Federal and State taxing authorities.
Loss Per Share	Basic and Diluted Earnings (Loss) per Share Pursuant to ASC 260-10-45, basic loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the periods presented. Diluted loss per share is computed by dividing net loss by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. The computation of basic and diluted loss per share for June 30, 2022 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive: June 30, Class A Warrants (Exercise price - $1.25/share) 38,985,020 Class B Warrants (Exercise price - $1.50/share) 38,985,020 Class C Warrants (Exercise price - $1.75/share) 38,985,020 Class D Warrants (Exercise price - $2.00/share) 38,985,020 Total 155,940,080
Related Parties	Related Parties Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.
Recent Accounting Standards	Recent Accounting Standards Changes to accounting principles are established by the FASB in the form of ASU’s to the FASB’s Codification. We consider the applicability and impact of all ASU’s on our consolidated financial position, results of operations, stockholders’ deficit, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the FASB in the form of Accounting Standards Updates (“ASU”) through the date these financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective accounting pronouncements, when adopted, will have a material impact on the consolidated financial statements of the Company. In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance, entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year. We adopted this pronouncement on January 1, 2022; however, the adoption of this standard did not have a material effect on the Company’s consolidated financial statements. In May 2021, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company does not expect the adoption of this standard to have a material effect on the Company’s consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. While the Company is continuing to assess the timing of adoption and the potential impacts of ASU 2021-08, it does not expect ASU 2021-08 will have a material effect, if any, on its consolidated financial statements.
Advertising Costs	Advertising Costs Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expense in the statements of operations. For the three and six months ended June 30, 2022, the Company recognized $2,303 and $3,458 in marketing and advertising costs.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. The Company uses the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The fair value of stock-based compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods. When determining fair value, the Company considers the following assumptions in the Black-Scholes model: ● Exercise price, ● Expected dividends, ● Expected volatility, ● Risk-free interest rate; and ● Expected life of option
Research and Development	Research and Development Research and development (“R&D”) costs are expensed as incurred. Major components of research and development costs include fees paid to consultants and other entities that conduct certain research and development activities on the Company’s behalf. Costs for research and development activities are recognized based on the terms of the individual arrangements, which may differ from the timing of receipt of invoices and payment of invoices and are reflected in the financial statements as an accrued expense. For the three and six months ended June 30, 2022, the Company expensed $82,024 and $77,990 in research and development costs.
Operating Lease	Operating Lease From time to time we may enter into operating lease or sub-lease agreements, including our corporate headquarters. We account for leases in accordance with ASC Topic 842: Leases, which requires a lessee to utilize the right-of-use model and to record a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either financing or operating, with classification affecting the pattern of expense recognition in the statement of operations. In addition, a lessor is required to classify leases as either sales-type, financing or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as financing. If the lessor does not convey risk and rewards or control, the lease is treated as operating. We determine if an arrangement is a lease, or contains a lease, at inception and record the lease in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term. Lease right-of-use assets and liabilities at commencement are initially measured at the present value of lease payments over the lease term. We generally use our incremental borrowing rate based on the information available at commencement to determine the present value of lease payments except when an implicit interest rate is readily determinable. We determine our incremental borrowing rate based on market sources including relevant industry data. We have lease agreements with lease and non-lease components and have elected to utilize the practical expedient to account for lease and non-lease components together as a single combined lease component, from both a lessee and lessor perspective with the exception of direct sales-type leases and production equipment classes embedded in supply agreements. From a lessor perspective, the timing and pattern of transfer are the same for the non-lease components and associated lease component and, the lease component, if accounted for separately, would be classified as an operating lease. We have elected not to present short-term leases on the balance sheet as these leases have a lease term of 12 months or less at lease inception and do not contain purchase options or renewal terms that we are reasonably certain to exercise. All other lease assets and lease liabilities are recognized based on the present value of lease payments over the lease term at commencement date. Because most of our leases do not provide an implicit rate of return, we used our incremental borrowing rate based on the information available at lease commencement date in determining the present value of lease payments. Our leases, where we are the lessee, do not include an option to extend the lease term. Our lease also includes an option to terminate the lease prior to the end of the agreed upon lease term. For purposes of calculating lease liabilities, lease term would include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, included as a component of general and administrative expenses, in the accompanying statements of operations. Certain operating leases provide for annual increases to lease payments based on an index or rate, our lease has no stated increase, payments were fixed at lease inception. We calculate the present value of future lease payments based on the index or rate at the lease commencement date. Differences between the calculated lease payment and actual payment are expensed as incurred. See Note 5.
Inventories	Inventories Inventories consist of food and beverages and are stated at cost and are included in assets from discontinued operations.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of basic and diluted loss per share	June 30, Class A Warrants (Exercise price - $1.25/share) 38,985,020 Class B Warrants (Exercise price - $1.50/share) 38,985,020 Class C Warrants (Exercise price - $1.75/share) 38,985,020 Class D Warrants (Exercise price - $2.00/share) 38,985,020 Total 155,940,080

Stockholders_ Deficit (Tables)

Stockholders’ Deficit (Tables)	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of warrants exercised	Number of Weighted Weighted Balance, December 31, 2021 155,940,080 $ 1.625 13.25 Granted - - - Exercised - - - Cancelled/Forfeited - - - Balance, June 30, 2022 (Unaudited) 155,940,080 $ 1.625 12.76
Schedule of warrants outstanding	Exercise Price Warrants Weighted Average Aggregate $ 1.25 38,985,020 12.76 $ 350,475,330 $ 1.50 38,985,020 12.76 $ 340,729,075 $ 1.75 38,985,020 12.76 $ 330,982,820 $ 2.00 38,985,020 12.76 $ 321,236,565 Exercise Price Warrants Weighted Average Aggregate $ 1.25 38,985,020 13.25 $ 436,632,224 $ 1.50 38,985,020 13.25 $ 426,885,969 $ 1.75 38,985,020 13.25 $ 417,139,714 $ 2.00 38,985,020 13.25 $ 407,393,459

Commitments (Tables)

Commitments (Tables)	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of future minimum payments	2022 $ 39,574 2023 75,119 Total $ 114,693
Schedule of supplemental consolidated balance sheet	June 30, (Unaudited) Operating lease assets - right of use $ 106,866 Lease liability is summarized below: Lease Liability $ 108,035 Less: operating lease liability, current (74,562 ) Long term operating lease liability $ 33,473 Maturities of lease liabilities at June 30, 2022 are as follows: 2022 $ 39,574 2023 75,119 Total lease liability 114,693 Less: present value discount (6,658 ) Total lease liability $ 108,035
Schedule of supplemental disclosures of cash flow information related to leases	For the (Unaudited) Cash paid for operating lease liabilities $ 14,127

Discontinued Operations (Tables

Discontinued Operations (Tables)	6 Months Ended
	Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Consolidated Balance Sheet (Unaudited)	June 30, (Unaudited) Current Assets Cash $ 1,598 Inventory 1,220 Operating lease asset 5,687 Total Assets from Discontinued Operations $ 8,505 Current Liabilities Accounts payable and accrued expenses $ 261 Due to former officers 62,297 Operating lease liability 5,687 Total Liabilities from Discontinued Operations $ 68,245
Schedule of consolidated statements of operations (Unaudited)	For the Six June 30, (Unaudited) Sales $ 3,349 Costs and Expenses Food, beverage and supplies 3,978 Labor 3,605 Direct operating and occupancy 1,632 Professional fees 567 General and administrative 3,120 Goodwill impairment expense 5,396,944 Total cost and expenses 5,409,846 LOSS FROM DISCONTINUED OPERATIONS BEFORE INCOME TAXES (5,406,497 ) Provision for Income Taxes - LOSS FROM DISCONTINUED OPERATIONS $ (5,406,497 )

Plan of Merger and Reorganiza_2

Plan of Merger and Reorganization and Reverse Acquisition (Tables)	6 Months Ended
	Jun. 30, 2022
Plan of Merger and Reorganization and Reverse Acquisition [Abstract]
Schedule of fair value of the assets acquired	Consideration Common stock (6,347,004 shares of common stock ($1/share)) $ 6,347,004 Fair value of consideration transferred 6,347,004 Recognized amounts of identifiable assets acquired and liabilities assumed: Cash 1,009,074 Inventory 3,691 Operating Lease Asset 7,023 Total assets acquired 1,019,788 Accounts payable and accrued expenses 408 Operating lease liability 7,023 Due to former officers 62,297 Total liabilities assumed 69,728 Total identifiable net assets 950,060 Goodwill $ 5,396,944

Organization and Nature of Op_2

Organization and Nature of Operations (Details) - USD ($)		6 Months Ended
	Jul. 01, 2022	Jun. 30, 2022	Dec. 31, 2021
Organization and Nature of Operations (Details) [Line Items]
Shares issued to shareholder (in Shares)		5,000,000
Merger shares, description		On the effective date, of the Merger the stockholders of Makamer exchanged a total of 19,986,667 shares of Makamer common stock (representing 100% of Makamer’s outstanding shares) for an aggregate of 30,000,000 shares of common stock of the Company (the “Merger Shares”), with each Makamer stockholder receiving a pro rata portion (1.5 shares for each share held) of the Merger Shares based upon the total number of shares of Makamer common stock held by such Makamer stockholder immediately prior to the effective date.
Business development cash		$ 1,000,000
Agreed to return shares of common stock (in Shares)		1,450,000
Cancellation term		30 days
Common stock shares issued (in Shares)		36,347,004	26,132,421
Common stock shares outstanding (in Shares)		36,347,004	26,132,421
Net loss from continuing operations		$ 3,826,873
Net cash used in operating activities continued operations		766,036
Accumulated deficit		(9,564,904)	$ (331,534)
Stockholders’ equity		1,031,300
Working capital		943,257
Cash		$ 913,509
Subsequent Event [Member]
Organization and Nature of Operations (Details) [Line Items]
Inventory for sales price	$ 700

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Cash balances in excess of FDIC	$ 663,405	$ 663,405	$ 0
Exploration Abandonment and Impairment Expense		5,396,944
Marketing and advertising costs	2,303	3,458
Research and development expense	$ 82,024	$ 77,990

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share	Jun. 30, 2022 shares
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share [Line Items]
Total	155,940,080
Class A Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share [Line Items]
Total	38,985,020
Class B Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share [Line Items]
Total	38,985,020
Class C Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share [Line Items]
Total	38,985,020
Class D Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share [Line Items]
Total	38,985,020

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share (Parentheticals)	Jun. 30, 2022 $ / shares
Class A Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share (Parentheticals) [Line Items]
Warrants exercise price	$ 1.25
Class B Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share (Parentheticals) [Line Items]
Warrants exercise price	1.5
Class C Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share (Parentheticals) [Line Items]
Warrants exercise price	1.75
Class D Warrants [Member]
Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted loss per share (Parentheticals) [Line Items]
Warrants exercise price	$ 2

Notes Payable- Related Party (D

Notes Payable- Related Party (Details) - President [Member] - USD ($)			2 Months Ended	12 Months Ended
	Mar. 15, 2022	Oct. 02, 2021	Mar. 31, 2022	Dec. 31, 2021	Oct. 01, 2021
Notes Payable- Related Party (Details) [Line Items]
Promissory note		$ 350,000			$ 24,990
Repayment amount	$ 24,990		$ 160,000	$ 190,000
Due term		3 years
Debt balance amount				$ 160,000

Stockholders_ Deficit (Details)

Stockholders’ Deficit (Details) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2022	Jun. 30, 2022	Apr. 01, 2022	Dec. 31, 2021	Mar. 23, 2020
Stockholders’ Deficit (Details) [Line Items]
Common stock, authorized		250,000,000		250,000,000
Common stock, par value (in Dollars per share)					$ 0.0001
Intrinsic value for the warrants (in Dollars)		$ 1,343,423,789
Shares issued	180,120		2,626,751
Aggregate value (in Dollars)	$ 210,000		$ 3,062,500
Price per share (in Dollars per share)	$ 1.75		$ 1.75
Shares issued for cash	1,060,708
Aggregate value for cash (in Dollars)	$ 795,000
Shares returned		1,450,000
Shares issued		7,797,004
Fair value (in Dollars)		$ 6,347,004
Minimum [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, authorized					100,000,000
Price per share (in Dollars per share)	$ 1
Maximum [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, authorized					250,000,000
Price per share (in Dollars per share)	$ 2

Stockholders_ Deficit (Detail_2

Stockholders’ Deficit (Details) - Schedule of warrants exercised	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Schedule of warrants exercised [Abstract]
Number of Warrants, Beginning Balance | shares	155,940,080
Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 1.625
Weighted Average Remaining Contractual Life (in Years), Beginning Balance	13 years 3 months
Number of Warrants, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Life (in Years), Granted
Number of Warrants, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Contractual Life (in Years), Exercised
Number of Warrants, Cancelled/Forfeited | shares
Weighted Average Exercise Price, Cancelled/Forfeited | $ / shares
Weighted Average Remaining Contractual Life (in Years), Cancelled/Forfeited
Number of Warrants, Ending Balance | shares	155,940,080
Weighted Average Exercise Price, Ending Balance | $ / shares	$ 1.625
Weighted Average Remaining Contractual Life (in Years), Ending Balance	12 years 9 months 3 days

Stockholders_ Deficit (Detail_3

Stockholders’ Deficit (Details) - Schedule of warrants outstanding - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Exercise Prices One [Member]
Stockholders’ Deficit (Details) - Schedule of warrants outstanding [Line Items]
Warrants Outstanding, Exercise Price	$ 1.25	$ 1.25
Warrants Exercisable, Number Exercisable	38,985,020	38,985,020
Warrants Outstanding, Weighted - Average Remaining Contractual Life	12 years 9 months 3 days	13 years 3 months
Warrants Aggregate Intrinsic Value	$ 350,475,330	$ 436,632,224
Exercise Prices Two [Member]
Stockholders’ Deficit (Details) - Schedule of warrants outstanding [Line Items]
Warrants Outstanding, Exercise Price	$ 1.5	$ 1.5
Warrants Exercisable, Number Exercisable	38,985,020	38,985,020
Warrants Outstanding, Weighted - Average Remaining Contractual Life	12 years 9 months 3 days	13 years 3 months
Warrants Aggregate Intrinsic Value	$ 340,729,075	$ 426,885,969
Exercise Prices Three [Member]
Stockholders’ Deficit (Details) - Schedule of warrants outstanding [Line Items]
Warrants Outstanding, Exercise Price	$ 1.75	$ 1.75
Warrants Exercisable, Number Exercisable	38,985,020	38,985,020
Warrants Outstanding, Weighted - Average Remaining Contractual Life	12 years 9 months 3 days	13 years 3 months
Warrants Aggregate Intrinsic Value	$ 330,982,820	$ 417,139,714
Exercise Prices Four [Member]
Stockholders’ Deficit (Details) - Schedule of warrants outstanding [Line Items]
Warrants Outstanding, Exercise Price	$ 2	$ 2
Warrants Exercisable, Number Exercisable	38,985,020	38,985,020
Warrants Outstanding, Weighted - Average Remaining Contractual Life	12 years 9 months 3 days	13 years 3 months
Warrants Aggregate Intrinsic Value	$ 321,236,565	$ 407,393,459

Commitments (Details)

Commitments (Details) - USD ($)									3 Months Ended	6 Months Ended
	Jun. 21, 2022	May 03, 2022	Apr. 01, 2022	Oct. 01, 2021	Sep. 15, 2021	Sep. 13, 2021	Apr. 26, 2021	Jul. 01, 2014	Jun. 30, 2022	Jun. 30, 2022	Apr. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Commitments (Details) [Line Items]
Annual salary					$ 120,000
Annual salary increase					$ 60,000
Base salary percentage					5%
Granted shares (in Shares)					375,000
Compensation amount									$ 15,000	$ 15,000
Shares of common stock (in Shares)			2,626,751									180,120
Shares price (in Dollars per share)											$ 1.75	$ 1.75
Consulting agreement fee per month							$ 7,500
Recorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year											$ 52,500
Vesting consideration totaling				$ 350,000
Price percentage		6%
Operating lease percentage									10%	10%
Initial present value									$ 10,569	$ 10,569
Rent expense									1,500	1,500
Security deposit									20,487	20,487
Operating lease rate								$ 500
Lease costs									$ 14,127	$ 14,127
Common Stock [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)											562,875
Common stock consideration											$ 656,250
Operating Lease Agreement [Member]
Commitments (Details) [Line Items]
Operating lease percentage									10%	10%
Initial present value									$ 118,891	$ 118,891
Operating lease payments for year one													$ 6,479
Operating lease payments for year two													$ 6,829
Rent expense									14,127	14,127
Advisory Services [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)				300,000							450,300
Common stock consideration											$ 525,000
Shares price (in Dollars per share)											$ 1.75
Sales and Advisory Services [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)				50,000							75,050
Common stock consideration											$ 87,500
Project fee amount			$ 5,000
Legal Services [Member]
Commitments (Details) [Line Items]
Fair value per share (in Dollars per share)				$ 1.75
Shares of common stock (in Shares)				10,000							15,010
Common stock consideration											$ 17,500
Shares price (in Dollars per share)											$ 1.75
Capital Raising and Investor [Member]
Commitments (Details) [Line Items]
Fair value per share (in Dollars per share)				$ 1.75
Shares of common stock (in Shares)				400,000							600,400
Common stock consideration											$ 700,000
Advisory Services and Consulting Services [Member]
Commitments (Details) [Line Items]
Fair value per share (in Dollars per share)				$ 1.75
Shares of common stock (in Shares)				200,000							300,200
Common stock consideration											$ 350,000
Marketing and Advertising Services [Member]
Commitments (Details) [Line Items]
Fair value per share (in Dollars per share)				$ 1.75
Shares of common stock (in Shares)				20,000							30,020
Common stock consideration											$ 35,000
Project fee amount			5,000
President [Member]
Commitments (Details) [Line Items]
Bonus amount	$ 100,000					$ 100,000
Fair value per share (in Dollars per share)						$ 0.0001
Fair value						$ 1,600
Annual bonus						350,000
Documentation amount	$ 100,000
Compensation amount									308,076	308,076
Accrued compensation										107,500
President [Member] | Bonus [Member]
Commitments (Details) [Line Items]
Annual bonus						100,000
President [Member] | Employment Agreements [Member]
Commitments (Details) [Line Items]
Annual salary						120,000
Annual salary increase						$ 350,000
Base salary percentage						55%
Granted shares (in Shares)						24,016,010
Chief Financial Officer [Member]
Commitments (Details) [Line Items]
Annual salary						$ 120,000
Annual salary increase						$ 220,000
Base salary percentage						55%
Granted shares (in Shares)						1,350,901
Fair value per share (in Dollars per share)						$ 0.0001
Fair value						$ 900
Annual bonus						350,000
Compensation amount									15,000	15,000
Accrued compensation										50,000
Employee salary reduced amount			$ 5,000
Chief Financial Officer [Member] | Bonus [Member]
Commitments (Details) [Line Items]
Annual bonus						100,000
Chief Operating Officer [Member]
Commitments (Details) [Line Items]
Fair value per share (in Dollars per share)				$ 1.75
Project fee amount				$ 5,000
Funds percentage				1.50%
Funds amount				$ 5,000,000
Chief Operating Officer [Member] | Common Stock [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)				60,090								90,000
Common stock consideration												$ 105,000
Additional shares (in Shares)				40,000
Chief Investment Officer [Member]
Commitments (Details) [Line Items]
Project fee amount				$ 5,000
Funds percentage				1.50%
Funds amount				$ 5,000,000
Chief Investment Officer [Member] | Common Stock [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)				60,000								90,000
Common stock consideration												$ 105,000
Additional shares (in Shares)				40,000
Vice President [Member]
Commitments (Details) [Line Items]
Shares price (in Dollars per share)											$ 1.75
Project fee amount											$ 5,000
Vice President [Member] | Common Stock [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)				20,000							30,020
Common stock consideration											$ 35,000
Research and Development Services [Member]
Commitments (Details) [Line Items]
Project fee amount						$ 10,000
General and administrative expenses									$ 30,000	$ 30,000
Research and Development Services [Member] | Common Stock [Member]
Commitments (Details) [Line Items]
Shares of common stock (in Shares)						375,000					562,875
Common stock consideration											$ 656,250
Shares price (in Dollars per share)											$ 1.75

Commitments (Details) - Schedul

Commitments (Details) - Schedule of future minimum payments	Jun. 30, 2022 USD ($)
Schedule of future minimum payments [Abstract]
2022	$ 39,574
2023	75,119
Total	$ 114,693

Commitments (Details) - Sched_2

Commitments (Details) - Schedule of supplemental consolidated balance sheet	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of supplemental consolidated balance sheet [Abstract]
Operating lease assets - right of use	$ 106,866
Lease liability is summarized below:
Lease Liability	108,035
Less: operating lease liability, current	(74,562)
Long term operating lease liability	33,473
2022	39,574
2023	75,119
Total lease liability	114,693
Less: present value discount	(6,658)
Total lease liability	$ 108,035

Commitments (Details) - Sched_3

Commitments (Details) - Schedule of supplemental disclosures of cash flow information related to leases	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of supplemental disclosures of cash flow information related to leases [Abstract]
Cash paid for operating lease liabilities	$ 14,127

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)

1 Months Ended

2 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Mar. 15, 2022

Oct. 02, 2021

Oct. 01, 2021

Sep. 13, 2021

Jul. 01, 2014

Mar. 31, 2022

Mar. 31, 2022

Jun. 30, 2022

Jun. 30, 2021

Jun. 30, 2022

Dec. 31, 2021

Sep. 13, 2022

Related Party Transactions (Details) [Line Items]

Employee bonus payment, description

During the employment period, the employee is also entitled to a guaranteed annual bonus for $100,000 for the first year of employment and $350,000 for each of the second and third year of employment. The guaranteed bonus is to be paid on a semi-annual basis with the first payment due six months from the date of the agreement. Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. As of April 1, 2022, employee monthly salary is reduced to $5,000 per month.

Common stock for consideration of consisting of service

$ 3,062,500

$ 3,272,500

Non-cancelable operating lease

On July 1, 2014, the Company entered into a five-year non-cancelable operating lease with a related party for its store space in Paulsboro, NJ at a monthly rate of $500.

Rent expense

1,500

$ 1,500

Operating Lease Agreement [Member]

Related Party Transactions (Details) [Line Items]

Monthly rate

$ 500

Unsecured Promissory Note [Member]

Related Party Transactions (Details) [Line Items]

Officers paid an aggregate expenses

$ 1,000

Balance due to officers

$ 62,297

62,297

President [Member]

Related Party Transactions (Details) [Line Items]

Employee granted shares of stock (in Shares)

24,016,010

Price per per share (in Dollars per share)

$ 0.0001

Fair value amount

$ 1,600

Employee bonus payment, description

Effective November 16, 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll. On June 21, 2022, the Company amended the agreement for the performance bonus. The employee is entitled a bonus of $100,000 if the Company merges with public Company and $100,000 if a documentary is produced on a television network. The company is also to reimburse the employee for any and all related federal, state and local taxes for the Company. For the six months ended June 30, 2022, the employee received a compensation of $308,076 and accrued compensation of $107,500 (See Note 5).On September  13, 2021, the Company entered into an employment agreement with its Chief Financial Officer, effective October 1, 2021. The initial term of the agreement is through October 1, 2024, at an annual salary of $120,000. An annual salary will increase to $220,000 upon Company’s common stock listed from OTC Markets-Pink Sheets to NASDAQ (the “Uplist”) or becoming a publicly traded Company. In addition, for each calendar year ending during the term of the agreement, the employee is eligible to receive an annual bonus with a target amount equal to 55% of the base salary earned by the employee. The employee was also granted 1,350,901 shares of the Company’s stock at the beginning of employment. The Company valued these shares at $0.0001/share with a fair value of $900. During the employment period, the employee is also entitled to a guaranteed annual bonus for $100,000 for the first year of employment and $350,000 for each of the second and third year of employment. The guaranteed bonus is to be paid on a semi-annual basis with the first payment due six months from the date of the agreement.

Employee received compensation amount

308,076

Accrued compensation

107,500

Promissory note

$ 350,000

$ 24,990

Repayment amount

$ 24,990

$ 160,000

190,000

Debt term

3 years

Balance amount

$ 160,000

Chief Financial Officer [Member]

Related Party Transactions (Details) [Line Items]

Annual salary

$ 120,000

Annual bonus target amount equal to percentage of employee

55%

Employee granted shares of stock (in Shares)

1,350,901

Price per per share (in Dollars per share)

$ 0.0001

Fair value amount

$ 900

Employee received compensation amount

15,000

Accrued compensation

$ 50,000

Chief Financial Officer [Member] | Maximum [Member]

Related Party Transactions (Details) [Line Items]

Annual salary

$ 220,000

Chief Operating Officer [Member]

Related Party Transactions (Details) [Line Items]

Price per per share (in Dollars per share)

$ 1.75

$ 1.75

Monthly project fee

$ 5,000

Consulting agreement, description

The consultant will also receive 1.5% of the funding as compensation for his role in raising funds for company after Company receives $5,000,000 in funding that results from consultants efforts. The consultant is also eligible to receive 60,090 shares of Common stock in 180 days upon the execution of the agreement and an additional 40,000 shares of Common Stock one year after entering the consulting agreement. Effective November 2021, and until March 31, 2022, the Company held off on paying and accruing any payroll.

Issuance shares of common stock (in Shares)

90,000

Common stock for consideration of consisting of service

$ 105,000

Agreement [Member] | President [Member]

Related Party Transactions (Details) [Line Items]

Annual salary

$ 120,000

Annual bonus target amount equal to percentage of employee

55%

Performance bonus

$ 100,000

Agreement [Member] | President [Member] | Maximum [Member]

Related Party Transactions (Details) [Line Items]

Annual salary

$ 350,000

Discontinued Operations (Detail

Discontinued Operations (Details) - Schedule of consolidated balance sheet (Unaudited)	Jun. 30, 2022 USD ($)
Current Assets
Cash	$ 1,598
Inventory	1,220
Operating lease asset	5,687
Total Assets from Discontinued Operations	8,505
Current Liabilities
Accounts payable and accrued expenses	261
Due to former officers	62,297
Operating lease liability	5,687
Total Liabilities from Discontinued Operations	$ 68,245

Discontinued Operations (Deta_2

Discontinued Operations (Details) - Schedule of consolidated statements of operations (Unaudited)	6 Months Ended
	Jun. 30, 2022 USD ($)
Schedule of consolidated statements of operations (Unaudited) [Abstract]
Sales	$ 3,349
Costs and Expenses
Food, beverage and supplies	3,978
Labor	3,605
Direct operating and occupancy	1,632
Depreciation
Professional fees	567
General and administrative	3,120
Goodwill impairment expense	5,396,944
Total cost and expenses	5,409,846
LOSS FROM DISCONTINUED OPERATIONS BEFORE INCOME TAXES	(5,406,497)
Provision for Income Taxes
LOSS FROM DISCONTINUED OPERATIONS	$ (5,406,497)

Plan of Merger and Reorganiza_3

Plan of Merger and Reorganization and Reverse Acquisition (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Plan of Merger and Reorganization and Reverse Acquisition (Details) [Line Items]
Total shares	19,986,667
Outstanding shares percentage	100%
Shares of common stock	30,000,000
Research and development (in Dollars)	$ 1,000,000
Common stock issued	36,347,004	26,132,421
Goodwill (in Dollars)	$ 5,396,944
Goodwill impairment (in Dollars)	$ 5,396,944
Makamer Holdings Inc [Member]
Plan of Merger and Reorganization and Reverse Acquisition (Details) [Line Items]
Shares of common stock	1,450,000

Plan of Merger and Reorganiza_4

Plan of Merger and Reorganization and Reverse Acquisition (Details) - Schedule of fair value of the assets acquired	6 Months Ended
	Jun. 30, 2022 USD ($)
Consideration
Common stock (6,347,004 shares of common stock ($1/share))	$ 6,347,004
Fair value of consideration transferred	6,347,004
Cash	1,009,074
Inventory	3,691
Operating Lease Asset	7,023
Total assets acquired	1,019,788
Accounts payable and accrued expenses	408
Operating lease liability	7,023
Due to former officers	62,297
Total liabilities assumed	69,728
Total identifiable net assets	950,060
Goodwill	$ 5,396,944

Plan of Merger and Reorganiza_5

Plan of Merger and Reorganization and Reverse Acquisition (Details) - Schedule of fair value of the assets acquired (Parentheticals)	Jun. 30, 2022 $ / shares shares
Schedule of fair value of the assets acquired [Abstract]
Common stock shares | shares	6,347,004
Common stock, per share | $ / shares	$ 1

Subsequent Event - Deconsolid_2

Subsequent Event - Deconsolidation of Subsidiary (Details) - Subsequent Event [Member] - USD ($)	Aug. 09, 2022	Jul. 01, 2022
Subsequent Event - Deconsolidation of Subsidiary (Details) [Line Items]
Inventory for sales price		$ 700
Subsequent event, description	the Company disposed of its subsidiary Your Hometown Deli, LLC for a price of $15,000, consisting of $5,000 to be paid in cash and $10,000 note receivable. The note receivable for $10,000, bearing interest at 8%, and due ninety days from the issuance of the note.